Stylam Industries Limited (STYLAMIND)
Transcript of Investor and Analyst Meet
AI summary
- Q1 FY27 EBITDA margin exceeded 21%, expected to sustain around 19-20% post new capex
- New plant commercial production starts September 2026, with 25-30% capacity utilization in first year
- New plant revenue guidance INR 250-300 Cr for FY27, ramp-up gradual month-on-month
- Domestic market restructuring ongoing; significant improvement expected from Q3 FY27 onwards
- Export markets stable; US tariffs remain at 10%, Europe and Middle East showing growth
- Raw material costs stable; price hikes taken in domestic market expected to sustain
- Employee costs stable; depreciation to increase post new plant commissioning
- Strategic partner Aica recently joined Board; technology transfer possible but no operational involvement yet
Source: Original filing PDF
—
view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts
BOT
🚨 STYLAMIND — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
📎 bseindia.com/xml-data/...
🎧 Audio summary ready
✓✓ 6:47 PM
Instant audio summaries2-min AI concall recap delivered with every earnings alert
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
Instant Telegram alertsResults, board meetings, insider trades — within minutes
Add STYLAMIND to your watchlist — all of this, automated.
Sign in with Google14-day Pro trial · No credit card · Cancel anytime
More on Stylam Industries Limited
Important.
The summary above is generated automatically from Stylam Industries Limited's own
public regulatory filing under SEBI LODR. Indian Stock Alerts is
not a SEBI-registered Research Analyst or Investment Adviser.
This page is informational, not investment advice, a recommendation to buy
or sell any security, or any opinion about the company's business, governance
or financial health. Always read the original filing before acting and consult
a registered adviser for investment decisions.